Myriad Genetics Inc (MYGN)
18.49
-0.01
(-0.05%)
USD |
NASDAQ |
Apr 22, 16:00
18.49
0.00 (0.00%)
Pre-Market: 20:00
Myriad Genetics Profit Margin (Quarterly): -15.87% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -15.87% |
| September 30, 2023 | -31.94% |
| June 30, 2023 | -63.27% |
| March 31, 2023 | -30.19% |
| December 31, 2022 | -23.79% |
| September 30, 2022 | -22.44% |
| June 30, 2022 | -7.86% |
| March 31, 2022 | -12.43% |
| December 31, 2021 | -4.73% |
| September 30, 2021 | 14.70% |
| June 30, 2021 | -2.48% |
| March 31, 2021 | -22.82% |
| September 30, 2020 | -10.47% |
| June 30, 2020 | -59.44% |
| March 31, 2020 | -70.24% |
| December 31, 2019 | -4.25% |
| September 30, 2019 | -11.06% |
| June 30, 2019 | -1.95% |
| March 31, 2019 | 3.19% |
| December 31, 2018 | 1.20% |
| September 30, 2018 | -0.35% |
| June 30, 2018 | 7.43% |
| March 31, 2018 | 4.97% |
| December 31, 2017 | 16.44% |
| September 30, 2017 | 44.07% |
| Date | Value |
|---|---|
| June 30, 2017 | 5.32% |
| March 31, 2017 | 2.13% |
| December 31, 2016 | 3.00% |
| September 30, 2016 | -0.68% |
| June 30, 2016 | 8.78% |
| March 31, 2016 | 18.11% |
| December 31, 2015 | 19.19% |
| September 30, 2015 | 16.51% |
| June 30, 2015 | 9.85% |
| March 31, 2015 | 11.89% |
| December 31, 2014 | 13.02% |
| September 30, 2014 | 9.48% |
| June 30, 2014 | 17.80% |
| March 31, 2014 | 20.10% |
| December 31, 2013 | 24.68% |
| September 30, 2013 | 27.39% |
| June 30, 2013 | 25.34% |
| March 31, 2013 | 24.22% |
| December 31, 2012 | 23.49% |
| September 30, 2012 | 22.58% |
| June 30, 2012 | 21.92% |
| March 31, 2012 | 22.82% |
| December 31, 2011 | 23.04% |
| September 30, 2011 | 22.72% |
| June 30, 2011 | 24.24% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-70.24%
Minimum
Mar 2020
14.70%
Maximum
Sep 2021
-21.14%
Average
-14.15%
Median
Profit Margin (Quarterly) Benchmarks
| Stryker Corp | 19.66% |
| Haemonetics Corp | 9.29% |
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 12.23% |
| Xtant Medical Holdings Inc | -15.31% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -33.56% |
| Return on Assets | -22.50% |
| Return on Invested Capital | -32.60% |
| Gross Profit Margin (Quarterly) | 68.67% |
| Operating Margin (Quarterly) | 41.40% |
| Return on Net Operating Assets | -24.21% |